Intervention A: Irinotecan; Oxaliplatin; Neulasta [clinicaltrials_resource:10d62746866ce640c226fd453fc44ae2]
intervention [clinicaltrials_vocabulary:intervention]
Intervention A: Irinotecan; Oxaliplatin; Neulasta [clinicaltrials_resource:10d62746866ce640c226fd453fc44ae2]
Bio2RDF identifier
10d62746866ce640c226fd453fc44ae2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:10d62746866ce640c226fd453fc44ae2
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Irinotecan (I.V.) 150-200 mg/m ...... s) 6 mg; Day 1 (every 5 weeks)
intervention name [clinicaltrials_vocabulary:intervention-name]
Intervention A: Irinotecan; Oxaliplatin; Neulasta
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:10d62746866ce640c226fd453fc44ae2
title
Intervention A: Irinotecan; Oxaliplatin; Neulasta
@en
type
label
Intervention A: Irinotecan; Ox ...... 62746866ce640c226fd453fc44ae2]
@en